Tranexamic acid for nose reconstruction after Mohs surgery
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests if tranexamic acid (a medicine that helps blood clot) reduces bleeding and bruising during nose reconstruction after skin cancer removal. It is for adults having a specific type of flap repair on their nose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You are having a flap repair of a nose defect after Mohs surgery, done by specific surgeons at Vanderbilt
- You cannot have any other face or sinus surgery at the same time
- You cannot be allergic to tranexamic acid (TXA)
- You cannot have a history of blood clots, stroke, heart attack, seizures, liver failure, or severe kidney disease
- You must not have a bleeding disorder or abnormal blood clotting test results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether tranexamic acid (a medicine that helps reduce bleeding) can lessen bleeding, swelling, and bruising after open rhinoplasty. You may be asked to take it around the time of surgery if you meet safety and lab criteria.
This study looks at the timing of a medicine called tranexamic acid, which is injected under the skin to reduce bleeding and bruising after Mohs surgery for skin cancer. If you are having Mohs surgery with same-day closure, you may be able to join.
This study looks at using a medicine called tranexamic acid (which helps reduce bleeding) during nose surgery, along with a precise way of giving another pain medicine (remifentanil) to keep you comfortable and stable. The goal is to find the best dose to reduce bleeding and improve recovery.
This Phase 3 trial tests whether giving tranexamic acid (a medicine that helps reduce bleeding) around the time of surgery can improve outcomes for people with invasive skin melanoma. It may help reduce surgical bleeding while keeping patients safe.
This early-phase study tests if giving tranexamic acid (a medicine that helps blood clot) through a mist into the nose and sinuses during sinus surgery can reduce bleeding. It is designed for adults who are otherwise healthy and undergoing a common type of sinus surgery called functional endoscopic sinus surgery (FESS).
This trial tests whether a powder form of tranexamic acid can stop nosebleeds faster in people who come to the emergency room with active bleeding. It may offer a new option if standard treatments don't work well.
Hear when a new Postoperative Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.